Advanced Medical Solutions Group (AMS)

Sector:

Health Care

Index:

FTSE AIM 50

210.50p
   
  • Change Today:
    -6.00p
  • 52 Week High: 258.00
  • 52 Week Low: 177.20
  • Currency: UK Pounds
  • Shares Issued: 217.41m
  • Volume: 1,110,630
  • Market Cap: £457.65m
  • RiskGrade: 156

Advanced Medical Solutions earnings to be impacted by sterilisation failure

By Duncan Ferris

Date: Friday 29 Nov 2019

LONDON (ShareCast) - (Sharecast News) - Advanced Medical Solutions on Friday warned that its full-year earnings could take a £2.0m hit due to a sterilisation failure at one of its third party partners.
As a result, many of the December orders for the surgical and advanced woundcare specialist's Liquiband topical adhesive product will not be sterilised and shipped to customers during the financial year ending 31 December 2019.

The unnamed supplier expects to resume operations in January, at which point the backlog will be addressed.

The company added that it did not expect any significant impact on end user sales due to the inventories held by its key customers.

Advanced Medical Solutions shares were down 2.63% at 259.00p at 1055 GMT.

Email this article to a friend

or share it with one of these popular networks:


Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

AMS Market Data

Currency UK Pounds
Share Price 210.50p
Change Today -6.00p
% Change -2.77 %
52 Week High 258.00
52 Week Low 177.20
Volume 1,110,630
Shares Issued 217.41m
Market Cap £457.65m
RiskGrade 156

AMS Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
71.56% below the market average71.56% below the market average71.56% below the market average71.56% below the market average71.56% below the market average
25.00% above the sector average25.00% above the sector average25.00% above the sector average25.00% above the sector average25.00% above the sector average
Price Trend
31.67% below the market average31.67% below the market average31.67% below the market average31.67% below the market average31.67% below the market average
22.22% above the sector average22.22% above the sector average22.22% above the sector average22.22% above the sector average22.22% above the sector average
Income
86.89% below the market average86.89% below the market average86.89% below the market average86.89% below the market average86.89% below the market average
33.33% below the sector average33.33% below the sector average33.33% below the sector average33.33% below the sector average33.33% below the sector average
Growth
37.71% below the market average37.71% below the market average37.71% below the market average37.71% below the market average37.71% below the market average
72.22% below the sector average72.22% below the sector average72.22% below the sector average72.22% below the sector average72.22% below the sector average

What The Brokers Say

Strong Buy 4
Buy 2
Neutral 2
Sell 1
Strong Sell 0
Total 9
buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

AMS Dividends

  Latest Previous
  Final Interim
Ex-Div 30-May-24 28-Sep-23
Paid 21-Jun-24 27-Oct-23
Amount 1.66p 0.70p

Trades for 17-May-2024

Time Volume / Share Price
16:39 51,000 @ 213.89p
16:39 51,000 @ 214.00p
16:38 50,000 @ 210.15p
16:36 75,000 @ 216.38p
16:35 65,766 @ 210.50p

AMS Key Personnel

CEO A Christopher (Chris) Meredith
CFO Eddie Johnson
Chair Liz Shanahan

Top of Page